CA2125149A1 - Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres affections par l'administration de s(-)felodipine optiquement pure - Google Patents

Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres affections par l'administration de s(-)felodipine optiquement pure

Info

Publication number
CA2125149A1
CA2125149A1 CA002125149A CA2125149A CA2125149A1 CA 2125149 A1 CA2125149 A1 CA 2125149A1 CA 002125149 A CA002125149 A CA 002125149A CA 2125149 A CA2125149 A CA 2125149A CA 2125149 A1 CA2125149 A1 CA 2125149A1
Authority
CA
Canada
Prior art keywords
felodipine
amount
composition according
administered
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002125149A
Other languages
English (en)
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2125149A1 publication Critical patent/CA2125149A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002125149A 1991-12-02 1992-12-01 Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres affections par l'administration de s(-)felodipine optiquement pure Abandoned CA2125149A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80131691A 1991-12-02 1991-12-02
US801,316 1991-12-02

Publications (1)

Publication Number Publication Date
CA2125149A1 true CA2125149A1 (fr) 1993-06-10

Family

ID=25180776

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002125149A Abandoned CA2125149A1 (fr) 1991-12-02 1992-12-01 Methodes et compositions pour le traitement de l'hypertension, de l'angor et d'autres affections par l'administration de s(-)felodipine optiquement pure

Country Status (5)

Country Link
EP (1) EP0661971A1 (fr)
JP (1) JPH07501551A (fr)
AU (2) AU3245493A (fr)
CA (1) CA2125149A1 (fr)
WO (1) WO1993010781A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501773D0 (sv) * 1995-05-15 1995-05-15 Astra Ab New use
PT1328273E (pt) * 2000-10-23 2008-09-23 Euro Celtique Sa Dispositivo e processos de administração transdérmica de felodipina
US7018649B2 (en) 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
EP0353238A1 (fr) * 1987-03-27 1990-02-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux produits intermediaires et procede
IT1230752B (it) * 1989-02-17 1991-10-29 Boehringer Biochemia Srl Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.

Also Published As

Publication number Publication date
EP0661971A4 (fr) 1995-02-09
EP0661971A1 (fr) 1995-07-12
WO1993010781A1 (fr) 1993-06-10
AU2221497A (en) 1997-07-31
JPH07501551A (ja) 1995-02-16
AU3245493A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
US6291490B1 (en) Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine
EP1262182A2 (fr) Procédés et compositions destinés à traiter l'hypertension, l'angine de poitrine et d'autres troubles à l'aide de (-) amlodipine optiquement pure
US6204281B1 (en) Method of treatment and pharmaceutical composition
US5508279A (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia
EP1262183A1 (fr) Utilisation du norastémizole dans le traitement de la rhinite allergique
US5834496A (en) Methods for treating hypertension using optically pure S(-) felodipine
US5571827A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
EP0661971A1 (fr) Procede et compositions therapeutiques de l'hypertension, de l'angine et d'autre troubles de la sante au moyen de felodipine s(-) optiquement pure
AU1016900A (en) Methods and compositions for treating hypertension, angina, and other disorders using optically pures(-) felodipine
AU1354000A (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
AU2006200150A1 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
EP1614420A2 (fr) Traitment de l'hypertension, de l'angine de poitrine et d'autres troubles avec (-)amlodipine
HK1029521A (en) Method and compositions for treating hypertensioin, angina and other disorders using optically pure (-) amlodipine.
AU711231B2 (en) Methods and compositions for treating hypertension, angina and other disorders using optically pure S(-) nitrendipine
US5510352A (en) Methods of using (+) doxazosin for the treatment of hypertension
WO1994009783A1 (fr) Procedes et compositions contenant de la doxazosine (-) utilises dans le traitement de l'adenome prostatique et de l'atherosclerose
WO1994007476A1 (fr) Procedes et compositions permettant de traiter l'hypertenson, les angines et d'autres affections au moyen de nitredipine s(-) optiquement pure
WO1994009782A1 (fr) Procedes et compositions de doxazosine (-) pour le traitement de l'hypertension
AU7252700A (en) Use of norastemizole for the treatment of allergic disorders

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20011203